Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
Recruiting · NCT05776056 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints | Brain Injuries, Traumatic, Craniocerebral Trauma, Stress Disorders, Traumatic, acute stress disorder, attention deficit hyperactivity disorder, inattentive type, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury, neurodevelopmental disorder, oppositional defiant disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 4 | 2026-08-19 | NCT05776056 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| VA Office of Research and Development | 472 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Birmingham VA Medical Center, Birmingham, AL | Birmingham | United States | 12 |
| Tuscaloosa VA Medical Center, Tuscaloosa, AL | Tuscaloosa | United States | 6 |
| VA Puget Sound Health Care System Seattle Division, Seattle, WA | Seattle | United States | 32 |